nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—kidney cancer—uterine fibroid	0.804	1	CtDrD
Sorafenib—HIPK3—endometrium—uterine fibroid	0.000782	0.00579	CbGeAlD
Sorafenib—MAPK11—female reproductive system—uterine fibroid	0.000778	0.00577	CbGeAlD
Sorafenib—FLT1—nipple—uterine fibroid	0.000777	0.00576	CbGeAlD
Sorafenib—MKNK2—myometrium—uterine fibroid	0.000776	0.00575	CbGeAlD
Sorafenib—RAF1—nipple—uterine fibroid	0.000773	0.00573	CbGeAlD
Sorafenib—ZAK—mammalian vulva—uterine fibroid	0.000773	0.00572	CbGeAlD
Sorafenib—TIE1—decidua—uterine fibroid	0.000769	0.0057	CbGeAlD
Sorafenib—EPHB6—nipple—uterine fibroid	0.000768	0.00569	CbGeAlD
Sorafenib—MKNK1—myometrium—uterine fibroid	0.000766	0.00568	CbGeAlD
Sorafenib—CDK7—female reproductive system—uterine fibroid	0.000765	0.00567	CbGeAlD
Sorafenib—AURKC—female reproductive system—uterine fibroid	0.000754	0.00558	CbGeAlD
Sorafenib—TIE1—urethra—uterine fibroid	0.000742	0.0055	CbGeAlD
Sorafenib—ZAK—uterus—uterine fibroid	0.000736	0.00545	CbGeAlD
Sorafenib—HIPK3—cardiac atrium—uterine fibroid	0.000724	0.00536	CbGeAlD
Sorafenib—MAPK11—female gonad—uterine fibroid	0.000708	0.00525	CbGeAlD
Sorafenib—RALBP1—myometrium—uterine fibroid	0.000701	0.00519	CbGeAlD
Sorafenib—BRAF—endometrium—uterine fibroid	0.0007	0.00519	CbGeAlD
Sorafenib—EPHA6—female reproductive system—uterine fibroid	0.000698	0.00517	CbGeAlD
Sorafenib—CDK7—female gonad—uterine fibroid	0.000696	0.00516	CbGeAlD
Sorafenib—TAOK2—female gonad—uterine fibroid	0.000691	0.00512	CbGeAlD
Sorafenib—TAOK2—vagina—uterine fibroid	0.000687	0.00509	CbGeAlD
Sorafenib—EPHX2—urethra—uterine fibroid	0.00068	0.00504	CbGeAlD
Sorafenib—TIE1—cardiac atrium—uterine fibroid	0.000677	0.00501	CbGeAlD
Sorafenib—TIE1—uterus—uterine fibroid	0.000673	0.00499	CbGeAlD
Sorafenib—FLT1—myometrium—uterine fibroid	0.000667	0.00494	CbGeAlD
Sorafenib—RAF1—myometrium—uterine fibroid	0.000663	0.00491	CbGeAlD
Sorafenib—ZAK—female reproductive system—uterine fibroid	0.000662	0.0049	CbGeAlD
Sorafenib—EPHB6—myometrium—uterine fibroid	0.000659	0.00488	CbGeAlD
Sorafenib—FGFR1—uterine cervix—uterine fibroid	0.000658	0.00488	CbGeAlD
Sorafenib—MAP2K5—nipple—uterine fibroid	0.000657	0.00487	CbGeAlD
Sorafenib—KDR—nipple—uterine fibroid	0.000657	0.00487	CbGeAlD
Sorafenib—HIPK3—female reproductive system—uterine fibroid	0.000647	0.0048	CbGeAlD
Sorafenib—EPHX2—mammalian vulva—uterine fibroid	0.000647	0.0048	CbGeAlD
Sorafenib—BRAF—uterus—uterine fibroid	0.000645	0.00478	CbGeAlD
Sorafenib—CSF1R—nipple—uterine fibroid	0.000641	0.00475	CbGeAlD
Sorafenib—FLT4—decidua—uterine fibroid	0.000636	0.00471	CbGeAlD
Sorafenib—MAP3K19—female reproductive system—uterine fibroid	0.000634	0.0047	CbGeAlD
Sorafenib—STK10—myometrium—uterine fibroid	0.000631	0.00468	CbGeAlD
Sorafenib—FGFR1—decidua—uterine fibroid	0.000627	0.00465	CbGeAlD
Sorafenib—MAP3K7—uterine cervix—uterine fibroid	0.000623	0.00462	CbGeAlD
Sorafenib—EPHX2—uterus—uterine fibroid	0.000617	0.00457	CbGeAlD
Sorafenib—MAP3K7—smooth muscle tissue—uterine fibroid	0.000606	0.00449	CbGeAlD
Sorafenib—TIE1—female reproductive system—uterine fibroid	0.000605	0.00448	CbGeAlD
Sorafenib—FGFR1—urethra—uterine fibroid	0.000605	0.00448	CbGeAlD
Sorafenib—MKNK2—uterine cervix—uterine fibroid	0.000604	0.00448	CbGeAlD
Sorafenib—ZAK—female gonad—uterine fibroid	0.000602	0.00446	CbGeAlD
Sorafenib—ZAK—vagina—uterine fibroid	0.000598	0.00443	CbGeAlD
Sorafenib—MKNK1—uterine cervix—uterine fibroid	0.000596	0.00442	CbGeAlD
Sorafenib—MAP3K7—decidua—uterine fibroid	0.000594	0.0044	CbGeAlD
Sorafenib—HIPK3—female gonad—uterine fibroid	0.000589	0.00437	CbGeAlD
Sorafenib—MKNK2—smooth muscle tissue—uterine fibroid	0.000587	0.00435	CbGeAlD
Sorafenib—HIPK3—vagina—uterine fibroid	0.000586	0.00434	CbGeAlD
Sorafenib—KIT—nipple—uterine fibroid	0.000582	0.00431	CbGeAlD
Sorafenib—FGFR1—mammalian vulva—uterine fibroid	0.000576	0.00427	CbGeAlD
Sorafenib—MKNK2—decidua—uterine fibroid	0.000576	0.00426	CbGeAlD
Sorafenib—MAP3K7—urethra—uterine fibroid	0.000573	0.00424	CbGeAlD
Sorafenib—PDGFRB—nipple—uterine fibroid	0.000569	0.00421	CbGeAlD
Sorafenib—MKNK1—decidua—uterine fibroid	0.000568	0.00421	CbGeAlD
Sorafenib—MAP3K7—endometrium—uterine fibroid	0.000564	0.00418	CbGeAlD
Sorafenib—MAP2K5—myometrium—uterine fibroid	0.000564	0.00418	CbGeAlD
Sorafenib—KDR—myometrium—uterine fibroid	0.000564	0.00418	CbGeAlD
Sorafenib—RET—decidua—uterine fibroid	0.000561	0.00416	CbGeAlD
Sorafenib—MKNK2—urethra—uterine fibroid	0.000555	0.00411	CbGeAlD
Sorafenib—FGFR1—cardiac atrium—uterine fibroid	0.000552	0.00409	CbGeAlD
Sorafenib—TIE1—female gonad—uterine fibroid	0.000551	0.00408	CbGeAlD
Sorafenib—FLT3—female reproductive system—uterine fibroid	0.00055	0.00408	CbGeAlD
Sorafenib—CSF1R—myometrium—uterine fibroid	0.00055	0.00408	CbGeAlD
Sorafenib—FGFR1—uterus—uterine fibroid	0.000549	0.00407	CbGeAlD
Sorafenib—MKNK1—urethra—uterine fibroid	0.000548	0.00406	CbGeAlD
Sorafenib—MKNK2—endometrium—uterine fibroid	0.000546	0.00405	CbGeAlD
Sorafenib—RALBP1—uterine cervix—uterine fibroid	0.000545	0.00404	CbGeAlD
Sorafenib—MAP3K7—mammalian vulva—uterine fibroid	0.000545	0.00404	CbGeAlD
Sorafenib—MKNK1—endometrium—uterine fibroid	0.000539	0.004	CbGeAlD
Sorafenib—RALBP1—smooth muscle tissue—uterine fibroid	0.00053	0.00393	CbGeAlD
Sorafenib—MKNK2—mammalian vulva—uterine fibroid	0.000528	0.00392	CbGeAlD
Sorafenib—BRAF—female gonad—uterine fibroid	0.000528	0.00391	CbGeAlD
Sorafenib—BRAF—vagina—uterine fibroid	0.000525	0.00389	CbGeAlD
Sorafenib—MAP3K7—cardiac atrium—uterine fibroid	0.000522	0.00387	CbGeAlD
Sorafenib—MKNK1—mammalian vulva—uterine fibroid	0.000522	0.00387	CbGeAlD
Sorafenib—RALBP1—decidua—uterine fibroid	0.00052	0.00385	CbGeAlD
Sorafenib—MAP3K7—uterus—uterine fibroid	0.000519	0.00385	CbGeAlD
Sorafenib—FLT1—uterine cervix—uterine fibroid	0.000519	0.00384	CbGeAlD
Sorafenib—RAF1—uterine cervix—uterine fibroid	0.000516	0.00382	CbGeAlD
Sorafenib—EPHB6—uterine cervix—uterine fibroid	0.000513	0.0038	CbGeAlD
Sorafenib—MKNK2—cardiac atrium—uterine fibroid	0.000506	0.00375	CbGeAlD
Sorafenib—EPHX2—female gonad—uterine fibroid	0.000504	0.00374	CbGeAlD
Sorafenib—FLT1—smooth muscle tissue—uterine fibroid	0.000504	0.00374	CbGeAlD
Sorafenib—MKNK2—uterus—uterine fibroid	0.000503	0.00373	CbGeAlD
Sorafenib—EPHX2—vagina—uterine fibroid	0.000501	0.00372	CbGeAlD
Sorafenib—RAF1—smooth muscle tissue—uterine fibroid	0.000501	0.00371	CbGeAlD
Sorafenib—RALBP1—urethra—uterine fibroid	0.000501	0.00371	CbGeAlD
Sorafenib—FLT3—female gonad—uterine fibroid	0.000501	0.00371	CbGeAlD
Sorafenib—FLT4—female reproductive system—uterine fibroid	0.0005	0.00371	CbGeAlD
Sorafenib—MKNK1—cardiac atrium—uterine fibroid	0.0005	0.0037	CbGeAlD
Sorafenib—KIT—myometrium—uterine fibroid	0.000499	0.0037	CbGeAlD
Sorafenib—FLT1—decidua—uterine fibroid	0.000494	0.00366	CbGeAlD
Sorafenib—RALBP1—endometrium—uterine fibroid	0.000493	0.00366	CbGeAlD
Sorafenib—RAF1—decidua—uterine fibroid	0.000491	0.00364	CbGeAlD
Sorafenib—STK10—uterine cervix—uterine fibroid	0.000491	0.00364	CbGeAlD
Sorafenib—EPHB6—decidua—uterine fibroid	0.000489	0.00362	CbGeAlD
Sorafenib—PDGFRB—myometrium—uterine fibroid	0.000488	0.00362	CbGeAlD
Sorafenib—RALBP1—mammalian vulva—uterine fibroid	0.000477	0.00354	CbGeAlD
Sorafenib—FLT1—urethra—uterine fibroid	0.000477	0.00353	CbGeAlD
Sorafenib—RAF1—urethra—uterine fibroid	0.000474	0.00351	CbGeAlD
Sorafenib—PDGFRA—smooth muscle tissue—uterine fibroid	0.000473	0.0035	CbGeAlD
Sorafenib—EPHB6—urethra—uterine fibroid	0.000471	0.00349	CbGeAlD
Sorafenib—FLT1—endometrium—uterine fibroid	0.000469	0.00348	CbGeAlD
Sorafenib—STK10—decidua—uterine fibroid	0.000468	0.00347	CbGeAlD
Sorafenib—RAF1—endometrium—uterine fibroid	0.000467	0.00346	CbGeAlD
Sorafenib—EPHB6—endometrium—uterine fibroid	0.000464	0.00344	CbGeAlD
Sorafenib—PDGFRA—decidua—uterine fibroid	0.000463	0.00343	CbGeAlD
Sorafenib—RALBP1—cardiac atrium—uterine fibroid	0.000457	0.00339	CbGeAlD
Sorafenib—FLT4—female gonad—uterine fibroid	0.000455	0.00337	CbGeAlD
Sorafenib—RALBP1—uterus—uterine fibroid	0.000455	0.00337	CbGeAlD
Sorafenib—FLT1—mammalian vulva—uterine fibroid	0.000454	0.00336	CbGeAlD
Sorafenib—MKNK2—female reproductive system—uterine fibroid	0.000453	0.00335	CbGeAlD
Sorafenib—RAF1—mammalian vulva—uterine fibroid	0.000451	0.00334	CbGeAlD
Sorafenib—FGFR1—female gonad—uterine fibroid	0.000449	0.00333	CbGeAlD
Sorafenib—EPHB6—mammalian vulva—uterine fibroid	0.000449	0.00333	CbGeAlD
Sorafenib—MKNK1—female reproductive system—uterine fibroid	0.000447	0.00331	CbGeAlD
Sorafenib—FGFR1—vagina—uterine fibroid	0.000446	0.00331	CbGeAlD
Sorafenib—MAP2K5—uterine cervix—uterine fibroid	0.000439	0.00325	CbGeAlD
Sorafenib—KDR—uterine cervix—uterine fibroid	0.000439	0.00325	CbGeAlD
Sorafenib—FLT1—cardiac atrium—uterine fibroid	0.000435	0.00322	CbGeAlD
Sorafenib—FLT1—uterus—uterine fibroid	0.000432	0.0032	CbGeAlD
Sorafenib—RAF1—cardiac atrium—uterine fibroid	0.000432	0.0032	CbGeAlD
Sorafenib—RAF1—uterus—uterine fibroid	0.00043	0.00319	CbGeAlD
Sorafenib—STK10—mammalian vulva—uterine fibroid	0.00043	0.00318	CbGeAlD
Sorafenib—EPHB6—cardiac atrium—uterine fibroid	0.00043	0.00318	CbGeAlD
Sorafenib—CSF1R—uterine cervix—uterine fibroid	0.000428	0.00317	CbGeAlD
Sorafenib—KDR—smooth muscle tissue—uterine fibroid	0.000426	0.00316	CbGeAlD
Sorafenib—MAP3K7—female gonad—uterine fibroid	0.000425	0.00315	CbGeAlD
Sorafenib—MAP3K7—vagina—uterine fibroid	0.000422	0.00313	CbGeAlD
Sorafenib—MAP2K5—decidua—uterine fibroid	0.000418	0.0031	CbGeAlD
Sorafenib—KDR—decidua—uterine fibroid	0.000418	0.0031	CbGeAlD
Sorafenib—CSF1R—smooth muscle tissue—uterine fibroid	0.000416	0.00308	CbGeAlD
Sorafenib—MKNK2—female gonad—uterine fibroid	0.000412	0.00305	CbGeAlD
Sorafenib—STK10—uterus—uterine fibroid	0.000409	0.00303	CbGeAlD
Sorafenib—MKNK2—vagina—uterine fibroid	0.000409	0.00303	CbGeAlD
Sorafenib—RALBP1—female reproductive system—uterine fibroid	0.000409	0.00303	CbGeAlD
Sorafenib—CSF1R—decidua—uterine fibroid	0.000408	0.00302	CbGeAlD
Sorafenib—MKNK1—female gonad—uterine fibroid	0.000407	0.00301	CbGeAlD
Sorafenib—PDGFRA—uterus—uterine fibroid	0.000405	0.003	CbGeAlD
Sorafenib—MKNK1—vagina—uterine fibroid	0.000404	0.00299	CbGeAlD
Sorafenib—KDR—urethra—uterine fibroid	0.000403	0.00299	CbGeAlD
Sorafenib—MAP2K5—urethra—uterine fibroid	0.000403	0.00299	CbGeAlD
Sorafenib—MAP2K5—endometrium—uterine fibroid	0.000397	0.00294	CbGeAlD
Sorafenib—KDR—endometrium—uterine fibroid	0.000397	0.00294	CbGeAlD
Sorafenib—CSF1R—urethra—uterine fibroid	0.000393	0.00292	CbGeAlD
Sorafenib—FLT1—female reproductive system—uterine fibroid	0.000389	0.00288	CbGeAlD
Sorafenib—KIT—uterine cervix—uterine fibroid	0.000389	0.00288	CbGeAlD
Sorafenib—CSF1R—endometrium—uterine fibroid	0.000387	0.00287	CbGeAlD
Sorafenib—RAF1—female reproductive system—uterine fibroid	0.000386	0.00286	CbGeAlD
Sorafenib—HTR2B—myometrium—uterine fibroid	0.000386	0.00286	CbGeAlD
Sorafenib—KDR—mammalian vulva—uterine fibroid	0.000384	0.00284	CbGeAlD
Sorafenib—MAP2K5—mammalian vulva—uterine fibroid	0.000384	0.00284	CbGeAlD
Sorafenib—PDGFRB—uterine cervix—uterine fibroid	0.00038	0.00281	CbGeAlD
Sorafenib—KIT—smooth muscle tissue—uterine fibroid	0.000378	0.0028	CbGeAlD
Sorafenib—CSF1R—mammalian vulva—uterine fibroid	0.000375	0.00278	CbGeAlD
Sorafenib—RALBP1—female gonad—uterine fibroid	0.000372	0.00276	CbGeAlD
Sorafenib—KIT—decidua—uterine fibroid	0.00037	0.00274	CbGeAlD
Sorafenib—RALBP1—vagina—uterine fibroid	0.00037	0.00274	CbGeAlD
Sorafenib—PDGFRB—smooth muscle tissue—uterine fibroid	0.000369	0.00273	CbGeAlD
Sorafenib—STK10—female reproductive system—uterine fibroid	0.000368	0.00273	CbGeAlD
Sorafenib—MAP2K5—cardiac atrium—uterine fibroid	0.000367	0.00272	CbGeAlD
Sorafenib—KDR—cardiac atrium—uterine fibroid	0.000367	0.00272	CbGeAlD
Sorafenib—KDR—uterus—uterine fibroid	0.000366	0.00271	CbGeAlD
Sorafenib—PDGFRA—female reproductive system—uterine fibroid	0.000364	0.0027	CbGeAlD
Sorafenib—PDGFRB—decidua—uterine fibroid	0.000362	0.00268	CbGeAlD
Sorafenib—CSF1R—cardiac atrium—uterine fibroid	0.000359	0.00266	CbGeAlD
Sorafenib—KIT—urethra—uterine fibroid	0.000357	0.00265	CbGeAlD
Sorafenib—CSF1R—uterus—uterine fibroid	0.000357	0.00264	CbGeAlD
Sorafenib—FLT1—female gonad—uterine fibroid	0.000354	0.00262	CbGeAlD
Sorafenib—RAF1—female gonad—uterine fibroid	0.000352	0.00261	CbGeAlD
Sorafenib—FLT1—vagina—uterine fibroid	0.000352	0.00261	CbGeAlD
Sorafenib—KIT—endometrium—uterine fibroid	0.000352	0.00261	CbGeAlD
Sorafenib—EPHB6—female gonad—uterine fibroid	0.00035	0.00259	CbGeAlD
Sorafenib—RAF1—vagina—uterine fibroid	0.00035	0.00259	CbGeAlD
Sorafenib—PDGFRB—urethra—uterine fibroid	0.000349	0.00259	CbGeAlD
Sorafenib—EPHB6—vagina—uterine fibroid	0.000348	0.00258	CbGeAlD
Sorafenib—PDGFRB—endometrium—uterine fibroid	0.000343	0.00254	CbGeAlD
Sorafenib—KIT—mammalian vulva—uterine fibroid	0.00034	0.00252	CbGeAlD
Sorafenib—STK10—female gonad—uterine fibroid	0.000335	0.00248	CbGeAlD
Sorafenib—STK10—vagina—uterine fibroid	0.000333	0.00247	CbGeAlD
Sorafenib—PDGFRB—mammalian vulva—uterine fibroid	0.000332	0.00246	CbGeAlD
Sorafenib—PDGFRA—female gonad—uterine fibroid	0.000331	0.00246	CbGeAlD
Sorafenib—PDGFRA—vagina—uterine fibroid	0.000329	0.00244	CbGeAlD
Sorafenib—MAP2K5—female reproductive system—uterine fibroid	0.000329	0.00244	CbGeAlD
Sorafenib—KDR—female reproductive system—uterine fibroid	0.000329	0.00244	CbGeAlD
Sorafenib—KIT—uterus—uterine fibroid	0.000324	0.0024	CbGeAlD
Sorafenib—CSF1R—female reproductive system—uterine fibroid	0.000321	0.00238	CbGeAlD
Sorafenib—PDGFRB—cardiac atrium—uterine fibroid	0.000318	0.00236	CbGeAlD
Sorafenib—PDGFRB—uterus—uterine fibroid	0.000316	0.00234	CbGeAlD
Sorafenib—CYP1A2—nipple—uterine fibroid	0.000308	0.00228	CbGeAlD
Sorafenib—HTR2B—uterine cervix—uterine fibroid	0.000301	0.00223	CbGeAlD
Sorafenib—MAP2K5—female gonad—uterine fibroid	0.000299	0.00222	CbGeAlD
Sorafenib—KDR—female gonad—uterine fibroid	0.000299	0.00222	CbGeAlD
Sorafenib—MAP2K5—vagina—uterine fibroid	0.000297	0.0022	CbGeAlD
Sorafenib—KDR—vagina—uterine fibroid	0.000297	0.0022	CbGeAlD
Sorafenib—HTR2B—smooth muscle tissue—uterine fibroid	0.000292	0.00217	CbGeAlD
Sorafenib—CSF1R—female gonad—uterine fibroid	0.000292	0.00216	CbGeAlD
Sorafenib—KIT—female reproductive system—uterine fibroid	0.000291	0.00216	CbGeAlD
Sorafenib—CSF1R—vagina—uterine fibroid	0.00029	0.00215	CbGeAlD
Sorafenib—HTR2B—decidua—uterine fibroid	0.000286	0.00212	CbGeAlD
Sorafenib—PDGFRB—female reproductive system—uterine fibroid	0.000284	0.00211	CbGeAlD
Sorafenib—ABCG2—myometrium—uterine fibroid	0.000274	0.00203	CbGeAlD
Sorafenib—HTR2B—endometrium—uterine fibroid	0.000272	0.00202	CbGeAlD
Sorafenib—KIT—female gonad—uterine fibroid	0.000265	0.00196	CbGeAlD
Sorafenib—KIT—vagina—uterine fibroid	0.000263	0.00195	CbGeAlD
Sorafenib—PDGFRB—female gonad—uterine fibroid	0.000259	0.00192	CbGeAlD
Sorafenib—PDGFRB—vagina—uterine fibroid	0.000257	0.00191	CbGeAlD
Sorafenib—ABCC4—uterus—uterine fibroid	0.000252	0.00187	CbGeAlD
Sorafenib—HTR2B—uterus—uterine fibroid	0.000251	0.00186	CbGeAlD
Sorafenib—HTR2C—female reproductive system—uterine fibroid	0.00024	0.00178	CbGeAlD
Sorafenib—PDGFRA—Signaling by EGFR—TNRC6B—uterine fibroid	0.000236	0.00388	CbGpPWpGaD
Sorafenib—CYP2B6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000236	0.00387	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000235	0.00385	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000234	0.00384	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by PDGF—TNRC6B—uterine fibroid	0.000234	0.00383	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by PDGF—TNRC6B—uterine fibroid	0.000233	0.00382	CbGpPWpGaD
Sorafenib—KIT—B Cell Activation—TNRC6B—uterine fibroid	0.000233	0.00382	CbGpPWpGaD
Sorafenib—MAP3K7—B Cell Activation—TNRC6B—uterine fibroid	0.000233	0.00382	CbGpPWpGaD
Sorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.000232	0.00381	CbGpPWpGaD
Sorafenib—PDGFRB—Downstream signal transduction—TNRC6B—uterine fibroid	0.000232	0.0038	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by FGFR—TNRC6B—uterine fibroid	0.00023	0.00378	CbGpPWpGaD
Sorafenib—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00023	0.00378	CbGpPWpGaD
Sorafenib—RAF1—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00023	0.00377	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000229	0.00376	CbGpPWpGaD
Sorafenib—CDK7—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000229	0.00376	CbGpPWpGaD
Sorafenib—PDGFRB—DAP12 signaling—TNRC6B—uterine fibroid	0.000228	0.00375	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling by NGF—TNRC6B—uterine fibroid	0.000227	0.00372	CbGpPWpGaD
Sorafenib—ABCC4—female reproductive system—uterine fibroid	0.000226	0.00168	CbGeAlD
Sorafenib—HTR2B—female reproductive system—uterine fibroid	0.000225	0.00167	CbGeAlD
Sorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.000225	0.00369	CbGpPWpGaD
Sorafenib—KIT—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000223	0.00366	CbGpPWpGaD
Sorafenib—CDK7—Disease—HPSE2—uterine fibroid	0.000223	0.00365	CbGpPWpGaD
Sorafenib—FGFR1—B Cell Activation—TNRC6B—uterine fibroid	0.000221	0.00363	CbGpPWpGaD
Sorafenib—PDGFRA—B Cell Activation—TNRC6B—uterine fibroid	0.000221	0.00362	CbGpPWpGaD
Sorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00022	0.00361	CbGpPWpGaD
Sorafenib—RAF1—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00022	0.0036	CbGpPWpGaD
Sorafenib—ABCC2—female reproductive system—uterine fibroid	0.000219	0.00162	CbGeAlD
Sorafenib—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000217	0.00356	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000216	0.00355	CbGpPWpGaD
Sorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000215	0.00352	CbGpPWpGaD
Sorafenib—PDGFRB—DAP12 interactions—TNRC6B—uterine fibroid	0.000215	0.00352	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000215	0.00352	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB4—PGR—uterine fibroid	0.000214	0.00351	CbGpPWpGaD
Sorafenib—ABCG2—uterine cervix—uterine fibroid	0.000213	0.00158	CbGeAlD
Sorafenib—PDGFRB—Signaling by EGFR—TNRC6B—uterine fibroid	0.000213	0.00349	CbGpPWpGaD
Sorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000212	0.00347	CbGpPWpGaD
Sorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000211	0.00346	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000211	0.00346	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by PDGF—TNRC6B—uterine fibroid	0.00021	0.00345	CbGpPWpGaD
Sorafenib—RAF1—Downstream signal transduction—TNRC6B—uterine fibroid	0.000206	0.00339	CbGpPWpGaD
Sorafenib—ABCC4—female gonad—uterine fibroid	0.000206	0.00153	CbGeAlD
Sorafenib—RAF1—Signaling by FGFR—TNRC6B—uterine fibroid	0.000205	0.00337	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000204	0.00335	CbGpPWpGaD
Sorafenib—HTR2B—vagina—uterine fibroid	0.000204	0.00151	CbGeAlD
Sorafenib—RAF1—DAP12 signaling—TNRC6B—uterine fibroid	0.000203	0.00334	CbGpPWpGaD
Sorafenib—ABCG2—decidua—uterine fibroid	0.000203	0.00151	CbGeAlD
Sorafenib—MAPK11—Cellular responses to stress—TNRC6B—uterine fibroid	0.000203	0.00333	CbGpPWpGaD
Sorafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000202	0.00332	CbGpPWpGaD
Sorafenib—UGT1A1—Biological oxidations—CYP17A1—uterine fibroid	0.000201	0.0033	CbGpPWpGaD
Sorafenib—UGT1A9—Biological oxidations—CYP17A1—uterine fibroid	0.000201	0.0033	CbGpPWpGaD
Sorafenib—RAF1—Leptin signaling pathway—ESR1—uterine fibroid	0.000201	0.0033	CbGpPWpGaD
Sorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0002	0.00329	CbGpPWpGaD
Sorafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0002	0.00327	CbGpPWpGaD
Sorafenib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000199	0.00327	CbGpPWpGaD
Sorafenib—PDGFRB—B Cell Activation—TNRC6B—uterine fibroid	0.000199	0.00326	CbGpPWpGaD
Sorafenib—UGT1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000199	0.00326	CbGpPWpGaD
Sorafenib—UGT1A9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000199	0.00326	CbGpPWpGaD
Sorafenib—CYP2C8—endometrium—uterine fibroid	0.000198	0.00147	CbGeAlD
Sorafenib—CYP3A5—uterine cervix—uterine fibroid	0.000198	0.00147	CbGeAlD
Sorafenib—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000198	0.00324	CbGpPWpGaD
Sorafenib—ABCG2—urethra—uterine fibroid	0.000196	0.00145	CbGeAlD
Sorafenib—ABCG2—endometrium—uterine fibroid	0.000193	0.00143	CbGeAlD
Sorafenib—RAF1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000191	0.00314	CbGpPWpGaD
Sorafenib—RAF1—DAP12 interactions—TNRC6B—uterine fibroid	0.000191	0.00314	CbGpPWpGaD
Sorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000191	0.00314	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—TNRC6B—uterine fibroid	0.00019	0.00312	CbGpPWpGaD
Sorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00019	0.00312	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00019	0.00311	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—TNRC6B—uterine fibroid	0.000188	0.00309	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000188	0.00308	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—TNRC6B—uterine fibroid	0.000187	0.00307	CbGpPWpGaD
Sorafenib—ABCG2—mammalian vulva—uterine fibroid	0.000187	0.00138	CbGeAlD
Sorafenib—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000178	0.00292	CbGpPWpGaD
Sorafenib—ABCG2—uterus—uterine fibroid	0.000178	0.00132	CbGeAlD
Sorafenib—KIT—Signaling by NGF—TNRC6B—uterine fibroid	0.000172	0.00281	CbGpPWpGaD
Sorafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000171	0.00281	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—MED12—uterine fibroid	0.000171	0.0028	CbGpPWpGaD
Sorafenib—CYP2C19—vagina—uterine fibroid	0.00017	0.00126	CbGeAlD
Sorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00017	0.00278	CbGpPWpGaD
Sorafenib—CYP3A7—Biological oxidations—CYP17A1—uterine fibroid	0.000169	0.00278	CbGpPWpGaD
Sorafenib—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000169	0.00277	CbGpPWpGaD
Sorafenib—CYP3A7—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000167	0.00274	CbGpPWpGaD
Sorafenib—BRAF—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000166	0.00272	CbGpPWpGaD
Sorafenib—CYP2C8—female reproductive system—uterine fibroid	0.000164	0.00122	CbGeAlD
Sorafenib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000164	0.00269	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—TNRC6B—uterine fibroid	0.000163	0.00267	CbGpPWpGaD
Sorafenib—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000162	0.00266	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—TNRC6B—uterine fibroid	0.000162	0.00266	CbGpPWpGaD
Sorafenib—BRAF—Disease—HPSE2—uterine fibroid	0.000161	0.00265	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling by Wnt—TNRC6B—uterine fibroid	0.000158	0.00259	CbGpPWpGaD
Sorafenib—KIT—Signaling by ERBB4—ESR1—uterine fibroid	0.00015	0.00247	CbGpPWpGaD
Sorafenib—CYP2C8—vagina—uterine fibroid	0.000149	0.0011	CbGeAlD
Sorafenib—CYP2B6—female reproductive system—uterine fibroid	0.000147	0.00109	CbGeAlD
Sorafenib—KIT—Disease—HPSE2—uterine fibroid	0.000147	0.00241	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—MED12—uterine fibroid	0.000147	0.00241	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—TNRC6B—uterine fibroid	0.000146	0.0024	CbGpPWpGaD
Sorafenib—CYP2C9—female reproductive system—uterine fibroid	0.000146	0.00108	CbGeAlD
Sorafenib—ABCG2—female gonad—uterine fibroid	0.000145	0.00108	CbGeAlD
Sorafenib—ABCG2—vagina—uterine fibroid	0.000145	0.00107	CbGeAlD
Sorafenib—FGFR1—Signaling by ERBB4—ESR1—uterine fibroid	0.000143	0.00234	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by ERBB4—ESR1—uterine fibroid	0.000142	0.00234	CbGpPWpGaD
Sorafenib—FGFR1—Disease—HPSE2—uterine fibroid	0.000139	0.00229	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—MED12—uterine fibroid	0.000139	0.00228	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—HPSE2—uterine fibroid	0.000139	0.00228	CbGpPWpGaD
Sorafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000139	0.00228	CbGpPWpGaD
Sorafenib—ABCB1—myometrium—uterine fibroid	0.000135	0.001	CbGeAlD
Sorafenib—CYP3A5—female gonad—uterine fibroid	0.000135	0.001	CbGeAlD
Sorafenib—CYP3A5—vagina—uterine fibroid	0.000134	0.000995	CbGeAlD
Sorafenib—CYP2B6—vagina—uterine fibroid	0.000133	0.000988	CbGeAlD
Sorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000132	0.00217	CbGpPWpGaD
Sorafenib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00013	0.00214	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—TNRC6B—uterine fibroid	0.00013	0.00214	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by ERBB4—ESR1—uterine fibroid	0.000128	0.0021	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—MED12—uterine fibroid	0.000126	0.00206	CbGpPWpGaD
Sorafenib—CYP2B6—Biological oxidations—CYP17A1—uterine fibroid	0.000125	0.00205	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—HPSE2—uterine fibroid	0.000125	0.00205	CbGpPWpGaD
Sorafenib—CYP2B6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000123	0.00203	CbGpPWpGaD
Sorafenib—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000122	0.00201	CbGpPWpGaD
Sorafenib—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000121	0.00198	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000119	0.00195	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000119	0.00195	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—CYP17A1—uterine fibroid	0.000116	0.00191	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB4—ESR1—uterine fibroid	0.000114	0.00187	CbGpPWpGaD
Sorafenib—MKNK1—Disease—TNRC6B—uterine fibroid	0.000113	0.00186	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000112	0.00184	CbGpPWpGaD
Sorafenib—RAF1—Disease—HPSE2—uterine fibroid	0.000112	0.00183	CbGpPWpGaD
Sorafenib—CYP3A4—female reproductive system—uterine fibroid	0.000111	0.000825	CbGeAlD
Sorafenib—CYP2D6—female reproductive system—uterine fibroid	0.00011	0.000812	CbGeAlD
Sorafenib—MAPK11—Innate Immune System—TNRC6B—uterine fibroid	0.000108	0.00178	CbGpPWpGaD
Sorafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000107	0.00176	CbGpPWpGaD
Sorafenib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000106	0.00174	CbGpPWpGaD
Sorafenib—ABCB1—uterine cervix—uterine fibroid	0.000105	0.00078	CbGeAlD
Sorafenib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000105	0.00172	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—MED12—uterine fibroid	0.000103	0.00168	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—MED12—uterine fibroid	0.000101	0.00165	CbGpPWpGaD
Sorafenib—ABCB1—decidua—uterine fibroid	0.0001	0.000743	CbGeAlD
Sorafenib—CYP2D6—female gonad—uterine fibroid	9.97e-05	0.000739	CbGeAlD
Sorafenib—KIT—Innate Immune System—TNRC6B—uterine fibroid	9.78e-05	0.00161	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—TNRC6B—uterine fibroid	9.78e-05	0.00161	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—TNRC6B—uterine fibroid	9.73e-05	0.0016	CbGpPWpGaD
Sorafenib—ABCB1—urethra—uterine fibroid	9.67e-05	0.000717	CbGeAlD
Sorafenib—RALBP1—Signaling Pathways—PGR—uterine fibroid	9.63e-05	0.00158	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—HPSE2—uterine fibroid	9.6e-05	0.00158	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—HPSE2—uterine fibroid	9.6e-05	0.00158	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—TNRC6B—uterine fibroid	9.57e-05	0.00157	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	9.52e-05	0.00156	CbGpPWpGaD
Sorafenib—ABCB1—endometrium—uterine fibroid	9.52e-05	0.000705	CbGeAlD
Sorafenib—FLT4—Signaling Pathways—PGR—uterine fibroid	9.48e-05	0.00155	CbGpPWpGaD
Sorafenib—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	9.46e-05	0.00155	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—TNRC6B—uterine fibroid	9.39e-05	0.00154	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—TNRC6B—uterine fibroid	9.39e-05	0.00154	CbGpPWpGaD
Sorafenib—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	9.33e-05	0.00153	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—TNRC6B—uterine fibroid	9.28e-05	0.00152	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—TNRC6B—uterine fibroid	9.26e-05	0.00152	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	9.24e-05	0.00152	CbGpPWpGaD
Sorafenib—ABCB1—mammalian vulva—uterine fibroid	9.21e-05	0.000682	CbGeAlD
Sorafenib—FGFR1—Adaptive Immune System—TNRC6B—uterine fibroid	8.92e-05	0.00146	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—TNRC6B—uterine fibroid	8.89e-05	0.00146	CbGpPWpGaD
Sorafenib—ABCB1—uterus—uterine fibroid	8.77e-05	0.00065	CbGeAlD
Sorafenib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	8.7e-05	0.00143	CbGpPWpGaD
Sorafenib—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	8.63e-05	0.00142	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—TNRC6B—uterine fibroid	8.59e-05	0.00141	CbGpPWpGaD
Sorafenib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	8.58e-05	0.00141	CbGpPWpGaD
Sorafenib—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	8.51e-05	0.0014	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—PGR—uterine fibroid	8.51e-05	0.0014	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—TNRC6B—uterine fibroid	8.34e-05	0.00137	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—HPSE2—uterine fibroid	8.15e-05	0.00134	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—HPSE2—uterine fibroid	8.08e-05	0.00133	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—TNRC6B—uterine fibroid	8.01e-05	0.00131	CbGpPWpGaD
Sorafenib—CDK7—Disease—TNRC6B—uterine fibroid	7.98e-05	0.00131	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TNRC6B—uterine fibroid	7.93e-05	0.0013	CbGpPWpGaD
Sorafenib—ABCB1—female reproductive system—uterine fibroid	7.88e-05	0.000584	CbGeAlD
Sorafenib—MKNK1—Signaling Pathways—PGR—uterine fibroid	7.85e-05	0.00129	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	7.73e-05	0.00127	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—MED12—uterine fibroid	7.51e-05	0.00123	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—TNRC6B—uterine fibroid	7.44e-05	0.00122	CbGpPWpGaD
Sorafenib—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	7.37e-05	0.00121	CbGpPWpGaD
Sorafenib—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	7.27e-05	0.00119	CbGpPWpGaD
Sorafenib—ABCB1—female gonad—uterine fibroid	7.17e-05	0.000532	CbGeAlD
Sorafenib—FLT1—Signaling Pathways—TNRC6B—uterine fibroid	7.14e-05	0.00117	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—TNRC6B—uterine fibroid	7.14e-05	0.00117	CbGpPWpGaD
Sorafenib—ABCB1—vagina—uterine fibroid	7.13e-05	0.000528	CbGeAlD
Sorafenib—FLT1—Signaling Pathways—PGR—uterine fibroid	7.07e-05	0.00116	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—TNRC6B—uterine fibroid	6.32e-05	0.00104	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—TNRC6B—uterine fibroid	6.28e-05	0.00103	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—PGR—uterine fibroid	6.22e-05	0.00102	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—HPSE2—uterine fibroid	5.97e-05	0.00098	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—HPSE2—uterine fibroid	5.84e-05	0.000958	CbGpPWpGaD
Sorafenib—BRAF—Disease—TNRC6B—uterine fibroid	5.78e-05	0.000948	CbGpPWpGaD
Sorafenib—KIT—Immune System—TNRC6B—uterine fibroid	5.7e-05	0.000935	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—TNRC6B—uterine fibroid	5.7e-05	0.000935	CbGpPWpGaD
Sorafenib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	5.69e-05	0.000934	CbGpPWpGaD
Sorafenib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	5.61e-05	0.000921	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—TNRC6B—uterine fibroid	5.41e-05	0.000887	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—TNRC6B—uterine fibroid	5.39e-05	0.000885	CbGpPWpGaD
Sorafenib—KIT—Disease—TNRC6B—uterine fibroid	5.26e-05	0.000863	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—ESR1—uterine fibroid	5.14e-05	0.000844	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—ESR1—uterine fibroid	5.06e-05	0.00083	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—HPSE2—uterine fibroid	5.06e-05	0.00083	CbGpPWpGaD
Sorafenib—FGFR1—Disease—TNRC6B—uterine fibroid	4.99e-05	0.000819	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—TNRC6B—uterine fibroid	4.98e-05	0.000817	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TNRC6B—uterine fibroid	4.88e-05	0.0008	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	4.86e-05	0.000798	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—TNRC6B—uterine fibroid	4.86e-05	0.000797	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—PGR—uterine fibroid	4.83e-05	0.000792	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TNRC6B—uterine fibroid	4.75e-05	0.00078	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PGR—uterine fibroid	4.7e-05	0.000772	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—ESR1—uterine fibroid	4.54e-05	0.000745	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—HPSE2—uterine fibroid	4.51e-05	0.000741	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	4.49e-05	0.000737	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—TNRC6B—uterine fibroid	4.49e-05	0.000736	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—HPSE2—uterine fibroid	4.41e-05	0.000723	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	4.34e-05	0.000712	CbGpPWpGaD
Sorafenib—RAF1—Immune System—TNRC6B—uterine fibroid	4.33e-05	0.000711	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—ESR1—uterine fibroid	4.19e-05	0.000688	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—HPSE2—uterine fibroid	4.15e-05	0.000681	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—HPSE2—uterine fibroid	4.12e-05	0.000675	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—MED12—uterine fibroid	4.11e-05	0.000675	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—MED12—uterine fibroid	4.11e-05	0.000675	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TNRC6B—uterine fibroid	4.09e-05	0.00067	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	4.07e-05	0.000668	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TNRC6B—uterine fibroid	4.05e-05	0.000664	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PGR—uterine fibroid	4.04e-05	0.000664	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PGR—uterine fibroid	4.01e-05	0.000657	CbGpPWpGaD
Sorafenib—RAF1—Disease—TNRC6B—uterine fibroid	4e-05	0.000656	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	3.96e-05	0.000649	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—ESR1—uterine fibroid	3.77e-05	0.000619	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TNRC6B—uterine fibroid	3.68e-05	0.000605	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TNRC6B—uterine fibroid	3.68e-05	0.000605	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PGR—uterine fibroid	3.65e-05	0.000598	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PGR—uterine fibroid	3.65e-05	0.000598	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	3.63e-05	0.000596	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HPSE2—uterine fibroid	3.52e-05	0.000577	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TNRC6B—uterine fibroid	3.5e-05	0.000574	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—MED12—uterine fibroid	3.49e-05	0.000573	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TNRC6B—uterine fibroid	3.49e-05	0.000572	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PGR—uterine fibroid	3.46e-05	0.000568	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—MED12—uterine fibroid	3.46e-05	0.000568	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PGR—uterine fibroid	3.45e-05	0.000566	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CYP17A1—uterine fibroid	3.44e-05	0.000565	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CYP17A1—uterine fibroid	3.44e-05	0.000565	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	3.38e-05	0.000555	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—ESR1—uterine fibroid	3.32e-05	0.000545	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	3.31e-05	0.000544	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TNRC6B—uterine fibroid	3.14e-05	0.000516	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PGR—uterine fibroid	3.11e-05	0.00051	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TNRC6B—uterine fibroid	3e-05	0.000492	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PGR—uterine fibroid	2.97e-05	0.000487	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CYP17A1—uterine fibroid	2.92e-05	0.000479	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CYP17A1—uterine fibroid	2.9e-05	0.000475	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	2.83e-05	0.000465	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TNRC6B—uterine fibroid	2.8e-05	0.000459	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PGR—uterine fibroid	2.77e-05	0.000455	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HPSE2—uterine fibroid	2.71e-05	0.000445	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—ESR1—uterine fibroid	2.58e-05	0.000423	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MED12—uterine fibroid	2.56e-05	0.00042	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—ESR1—uterine fibroid	2.51e-05	0.000412	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MED12—uterine fibroid	2.5e-05	0.00041	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TNRC6B—uterine fibroid	2.42e-05	0.000397	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PGR—uterine fibroid	2.39e-05	0.000393	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MED12—uterine fibroid	2.17e-05	0.000355	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—ESR1—uterine fibroid	2.16e-05	0.000354	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CYP17A1—uterine fibroid	2.14e-05	0.000351	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—ESR1—uterine fibroid	2.14e-05	0.000351	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CYP17A1—uterine fibroid	2.09e-05	0.000343	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—ESR1—uterine fibroid	1.95e-05	0.00032	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—ESR1—uterine fibroid	1.95e-05	0.00032	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MED12—uterine fibroid	1.93e-05	0.000317	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MED12—uterine fibroid	1.89e-05	0.00031	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—ESR1—uterine fibroid	1.85e-05	0.000303	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—ESR1—uterine fibroid	1.84e-05	0.000302	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	1.81e-05	0.000297	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MED12—uterine fibroid	1.78e-05	0.000292	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MED12—uterine fibroid	1.76e-05	0.000289	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—ESR1—uterine fibroid	1.66e-05	0.000272	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP17A1—uterine fibroid	1.62e-05	0.000266	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—ESR1—uterine fibroid	1.58e-05	0.00026	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP17A1—uterine fibroid	1.58e-05	0.000259	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MED12—uterine fibroid	1.51e-05	0.000247	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	1.49e-05	0.000244	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—ESR1—uterine fibroid	1.48e-05	0.000243	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP17A1—uterine fibroid	1.48e-05	0.000242	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—ESR1—uterine fibroid	1.28e-05	0.00021	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP17A1—uterine fibroid	1.26e-05	0.000207	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MED12—uterine fibroid	1.16e-05	0.000191	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	9.73e-06	0.00016	CbGpPWpGaD
